Efficient expression of recombinant soluble human FcγRI in mammalian cells and its characterization
Protein Expression and Purification, ISSN: 1046-5928, Vol: 82, Issue: 1, Page: 155-161
2012
- 4Citations
- 22Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef3
- Captures22
- Readers22
- 22
Article Description
The extracellular domain of human FcγRI which interacts with a human IgG was expressed as recombinant soluble human FcγRI (rshFcγRI) by Chinese hamster ovary (CHO) cell. Stable CHO cell clones with efficient expression of rshFcγRI were established based on a dihydrofolate reductase (DHFR)/methotrexate (MTX) gene-amplification system. The CHO clones efficiently produced rshFcγRI under high-density continuous culture in a bioreactor. After 53 days of culture, the number of cells had reached approximately 4 × 10 6 cells/mL in the bioreactor and the average production of rshFcγRI had reached 7.4 mg L-medium −1 day −1. Secreted rshFcγRI was purified to a homogeneous state using cation exchange and affinity chromatographies. The binding affinities of rshFcγRI to human IgG subclasses were determined using surface plasmon resonance analysis. The binding affinities of rshFcγRI to human IgG1/κ and IgG3/κ were high (1.59 × 10 −10 and 2.81 × 10 −10 M, respectively), whereas that of rshFcγRI to human IgG4/κ was lower binding affinity (1.41 × 10 −8 M). Binding to IgG2/κ was not detectable. Examination of circular dichroism spectra indicated that rshFcγRI was rich in β-structures and loop or turn structures, but there were few α-helices. These results may be valuable for further studies of the structure and function of human FcγRI.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1046592811003524; http://dx.doi.org/10.1016/j.pep.2011.12.006; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862794623&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/22226868; https://linkinghub.elsevier.com/retrieve/pii/S1046592811003524; https://dx.doi.org/10.1016/j.pep.2011.12.006
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know